Form 4 for IMNM Immunome Inc.
Accepted 2023-01-17 00:00:00 ET · period of report 2023-01-15 · accession 0001104659-23-004005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-17 | 2023-01-15 | IMNM | Lefenfeld Michael | Dir | A - Grant | $4.00 | +13.9K | 40.7K | +52% | +$55.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-15 | A | A | 13,875 | $4.00 | 40,747 | D | — | — | (F1) The shares of Common Stock were issued to the Reporting Person pursuant to the Issuer's 2020 Equity Compensation Plan in lieu of the non-employee director board and committee cash retainers of $55,500 in the aggregate owed to the Reporting Person for service on the board of directors in 2022. |